EMT Transition States during Tumor Progression and Metastasis.
暂无分享,去创建一个
[1] J. Cerhan,et al. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[3] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[4] T. Voet,et al. Identification of the tumour transition states occurring during EMT , 2018, Nature.
[5] E. Furth,et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.
[6] N. Loman,et al. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial , 2018, Breast Cancer Research.
[7] T. Keck,et al. Cancer cell invasion and EMT marker expression: a three‐dimensional study of the human cancer–host interface , 2014, The Journal of pathology.
[8] H. Levine,et al. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis? , 2018, Biochimica et biophysica acta. Reviews on cancer.
[9] C. Blanpain,et al. Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.
[10] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[11] D. Beer,et al. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. , 2017, Cancer research.
[12] C. Nelson,et al. A Collective Route to Head and Neck Cancer Metastasis , 2018, Scientific Reports.
[13] H. Popper,et al. Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated , 2018, BMC Cancer.
[14] A. G. de Herreros,et al. Wilms' Tumor Protein Induces an Epithelial-Mesenchymal Hybrid Differentiation State in Clear Cell Renal Cell Carcinoma , 2014, PloS one.
[15] R. Weinberg,et al. Upholding a role for EMT in breast cancer metastasis , 2017, Nature.
[16] Erik Sahai,et al. Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization , 2015, Cell reports.
[17] T. Möller,et al. Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. , 2009, Cancer research.
[18] D. Planchard,et al. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.
[19] M. Miyazaki,et al. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization , 2016, Genes & development.
[20] Jason T. George,et al. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling , 2018, bioRxiv.
[21] W. Choi,et al. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer , 2016, Oncotarget.
[22] Xin-hua Liang,et al. Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma , 2017, PloS one.
[23] Eshel Ben-Jacob,et al. Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model , 2015, Oncotarget.
[24] Stephen T. C. Wong,et al. In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors. , 2016, Cancer research.
[25] Hushan Yang,et al. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer , 2016, Breast Cancer Research and Treatment.
[26] Michael B. Stadler,et al. PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.
[27] N. Colburn,et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Onuchic,et al. Numb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling , 2017, Journal of The Royal Society Interface.
[29] H. Levine,et al. Clinical Medicine , 1997 .
[30] C. Pilarsky,et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.
[31] Joseph Rosenbluh,et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.
[32] N. Jordan,et al. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer , 2011, Cell cycle.
[33] M. Noguchi,et al. Clinical significance of E-cadherin and vimentin co-expression in breast cancer. , 1996, International journal of oncology.
[34] S. Sen,et al. CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer , 2018, Scientific Reports.
[35] Hushan Yang,et al. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer , 2015, Breast Cancer Research and Treatment.
[36] R. Paus,et al. Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin , 2010, Molecular and Cellular Biology.
[37] R. Plummer,et al. Detection of circulating tumour cell clusters in human glioblastoma , 2018, British Journal of Cancer.
[38] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[39] Andrew J Armstrong,et al. Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .
[40] Y. Sugisaki,et al. Pulmonary carcinosarcoma: Immunohistochemical and ultrastructural studies , 1999, Pathology international.
[41] A. Tajima,et al. Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations. , 2018, Lung cancer.
[42] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[43] Jeffrey D. Varner,et al. Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1 , 2015, bioRxiv.
[44] R. Weinberg,et al. Upholding a role for EMT in pancreatic cancer metastasis , 2017, Nature.
[45] Mohit Kumar Jolly,et al. Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. , 2017, Cancer research.
[46] Bogi Andersen,et al. Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. , 2014, Developmental cell.
[47] M Choolani,et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) , 2013, Cell Death and Disease.
[48] M. Vaidya,et al. Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients , 2017, PloS one.
[49] G. Charras,et al. In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity , 2014, The Journal of cell biology.
[50] E. Tokunaga,et al. Epithelial Paradox: Clinical Significance of Coexpression of E‐cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer , 2018, Clinical breast cancer.
[51] D. Gilmour,et al. EMT 2.0: shaping epithelia through collective migration. , 2009, Current opinion in genetics & development.
[52] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[53] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[54] K. Sundfeldt,et al. TGF-β isoforms induce EMT independent migration of ovarian cancer cells , 2014, Cancer Cell International.
[55] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[56] Eshel Ben-Jacob,et al. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..
[57] R. Cason,et al. Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the question , 2015, Virchows Archiv.
[58] Cecilia Clementi,et al. Jagged–Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype , 2015, Proceedings of the National Academy of Sciences.
[59] T. Brabletz. To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.
[60] Caroline Dive,et al. Circulating tumor cells as a window on metastasis biology in lung cancer. , 2011, The American journal of pathology.
[61] Shawn M. Gillespie,et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.
[62] L. Ellis,et al. Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression , 2014, Clinical Cancer Research.
[63] Antonio Rosato,et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth , 2015, Nature Cell Biology.
[64] Zhan-jun Chen,et al. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma , 2018, Digestive Diseases and Sciences.
[65] Eshel Ben-Jacob,et al. OVOL guides the epithelial-hybrid-mesenchymal transition , 2015, Oncotarget.
[66] D. Zheng,et al. ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas , 2015, eLife.
[67] M. Hendrix,et al. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.
[68] P. Bertolazzi,et al. Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines , 2017, Oncotarget.
[69] Dong Wang,et al. Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts , 2013, Stem cell reports.
[70] G. Berx,et al. Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.
[71] R. Weinberg,et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells , 2015, Nature.
[72] A. Puisieux,et al. Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.
[73] S. Fischer,et al. Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis. , 2009, Histology and histopathology.
[74] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[75] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[76] Xudong Dai,et al. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. , 2015, Cancer research.
[77] D. Mavroudis,et al. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer , 2015, BMC Cancer.
[78] King-Jen Chang,et al. Rab11 collaborates E‐cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma , 2016, European journal of clinical investigation.
[79] C. Perou,et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.
[80] M. Nieto,et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.
[81] J. Bartek,et al. Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity , 2011, PLoS ONE.
[82] G. V. van Leenders,et al. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer , 2015, Oncotarget.
[83] Tian Hong,et al. An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States , 2015, PLoS Comput. Biol..
[84] R. Kurman,et al. The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus: A Clinicopathologic and Immunohistochemical Study , 1990, The American journal of surgical pathology.
[85] Andrew J. Ewald,et al. Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program , 2013, Cell.
[86] Jean Paul Thiery,et al. EMT: 2016 , 2016, Cell.
[87] A. del Sol,et al. Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival , 2015, PloS one.
[88] E. Ben-Jacob,et al. Stability of the hybrid epithelial/mesenchymal phenotype , 2016, Oncotarget.
[89] Jingyu Zhang,et al. TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops , 2014, Science Signaling.
[90] P. Friedl,et al. Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.
[91] Eshel Ben-Jacob,et al. Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis , 2015, Scientific Reports.
[92] J. Casanova,et al. A common framework for EMT and collective cell migration , 2016, Development.
[93] R. Gomis,et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.
[94] Inna Kuperstein,et al. Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut , 2014, Nature Communications.
[95] V. LeBleu,et al. EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.
[96] R. Yi,et al. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition. , 2017, Cell stem cell.
[97] M. Garcia-Blanco,et al. Carcinosarcomas: tumors in transition? , 2015, Histology and histopathology.
[98] T. Tan,et al. Molecular characterization of breast cancer CTCs associated with brain metastasis , 2017, Nature Communications.
[99] S. Rorive,et al. YAP and TAZ are essential for basal and squamous cell carcinoma initiation , 2018, EMBO reports.
[100] Stephen T. C. Wong,et al. EMT is not required for lung metastasis but contributes to chemoresistance , 2016 .
[101] Hong Wu,et al. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. , 2015, Cancer research.
[102] T. Kamarul,et al. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype , 2018, Journal of Biomedical Science.
[103] I. Mackenzie,et al. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. , 2011, Cancer research.
[104] P. Bendahl,et al. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort , 2016, BMC Cancer.
[105] J. Keene,et al. Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion , 2018, iScience.
[106] Albert C. Chen,et al. Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.
[107] R. Cason,et al. Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing , 2014, Virchows Archiv.
[108] May Yin Lee,et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.
[109] N. Yang,et al. Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers , 2015, PloS one.
[110] Jill M. Westcott,et al. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program. , 2015, Cancer research.
[112] W. Woodward,et al. Inflammatory breast cancer: a model for investigating cluster-based dissemination , 2017, npj Breast Cancer.
[113] R. Zeillinger,et al. Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance , 2017, Scientific Reports.
[114] D. Grignon,et al. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. , 1993, Archives of pathology & laboratory medicine.